| Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
 Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
  
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
   English Wikipedia
 
 Nephropedia Template TP (
 
 Twit Text
 
 
 DeepDyve
 Pubget Overpricing
 | lüll   
 
 New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall  biology Patterson C; Stouffer GA; Madamanchi N; Runge MSCirc Res  2001[May]; 88 (10): 987-97Thrombin is a serine protease that potently activates platelets and catalyzes the  conversion of fibrinogen to fibrin. Thrombin also exerts direct effects on  vascular cells, such as smooth muscle cells, via interactions with members of the  protease-activated receptor family. Evidence in several animal models implicates  thrombin-mediated signaling events in the response to injury that typifies  vascular lesion formation in atherosclerosis and restenosis. In this review, we  examine the activation of protease-activated receptors by thrombin, the  downstream signaling events mediated by these receptors, and the physiological  role of thrombin in vascular cells and vascular disease.|Animals[MESH]|Apoptosis[MESH]|Blood Vessels/drug effects/*metabolism[MESH]|Cell Division/drug effects[MESH]|Cell Movement/drug effects[MESH]|Endothelium, Vascular/drug effects/physiology[MESH]|Enzyme Activation/physiology[MESH]|Humans[MESH]|Muscle, Smooth, Vascular/drug effects/*metabolism[MESH]|Neovascularization, Physiologic/drug effects[MESH]|Plasminogen Activator Inhibitor 1/metabolism[MESH]|Receptor, PAR-1[MESH]|Receptors, Thrombin/metabolism[MESH]|Signal Transduction/drug effects/physiology[MESH]|Thrombin/antagonists & inhibitors/*metabolism/pharmacology[MESH]
 |